A New Synthetic Approach to 1-[(3R,4R)-1-Cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-benzimidazol-2-one (J-113397), the first non-peptide ORL-1 receptor antagonist
- 19 June 2001
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 9 (7), 1871-1877
- https://doi.org/10.1016/s0968-0896(01)00085-2
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The potential therapeutic value of nociceptin receptor agonists and antagonistsExpert Opinion on Therapeutic Patents, 2000
- High-Affinity, Non-Peptide Agonists for the ORL1 (Orphanin FQ/Nociceptin) ReceptorJournal of Medicinal Chemistry, 2000
- The opioid-receptor-like 1 (ORL-1) as a potential target for new analgesicsEuropean Journal of Medicinal Chemistry, 2000
- Discovery of the First Potent and Selective Small Molecule Opioid Receptor-like (ORL1) Antagonist: 1-[(3R,4R)-1-Cyclooctylmethyl-3- hydroxymethyl-4-piperidyl]-3-ethyl- 1,3-dihydro-2H-benzimidazol-2-one (J-113397)Journal of Medicinal Chemistry, 1999
- A Note on the Iwasawa .LAMBDA.-Invariants of Real Abelian Number Fields.Interdisciplinary Information Sciences, 1998
- The orphan opioid receptor and its endogenous ligand — nociceptin/orphanin FQTrends in Pharmacological Sciences, 1997
- Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled ReceptorScience, 1995
- Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptorNature, 1995
- Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a μ, δ or κ opioid receptor typeFEBS Letters, 1994
- ORL1, a novel member of the opioid receptor familyFEBS Letters, 1994